Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. 2009

Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.

This study systematically analyzes platelet-derived growth factor (PDGF) receptor expression in six types of common tumors as well as examines associations between PDGF beta-receptor status and clinicopathological characteristics in breast cancer. PDGF receptor expression was determined by immunohistochemistry on tumor tissue microarrays. Breast tumor data were combined with prognostic factors and related to outcome endpoints. PDGF alpha- and beta-receptors were independently expressed, at variable frequencies, in the tumor stroma of all tested tumor types. There was a significant association between PDGF beta-receptor expression on fibroblasts and perivascular cells in individual colon and prostate tumors. In breast cancer, high stromal PDGF beta-receptor expression was significantly associated with high histopathological grade, estrogen receptor negativity, and high HER2 expression. High stromal PDGF beta-receptor expression was correlated with significantly shorter recurrence-free and breast cancer-specific survival. The prognostic significance of stromal PDGF beta-receptor expression was particularly prominent in tumors from premenopausal women. Stromal PDGF alpha- and beta-receptor expression is a common, but variable and independent, property of solid tumors. In breast cancer, stromal PDGF beta-receptor expression significantly correlates with less favorable clinicopathological parameters and shorter survival. These findings highlight the prognostic significance of stromal markers and should be considered in ongoing clinical development of PDGF receptor inhibitors.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003238 Connective Tissue Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX. Connective Tissues,Tissue, Connective,Tissues, Connective
D005260 Female Females

Related Publications

Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
December 1993, Laboratory investigation; a journal of technical methods and pathology,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
June 1995, Cancer research,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
January 1994, Surgery today,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
April 1996, Clinical cancer research : an official journal of the American Association for Cancer Research,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
January 2007, Anticancer research,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
February 2021, Cancer research,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
January 1999, Journal of molecular neuroscience : MN,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
February 1990, Cancer research,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
November 1998, Journal of dermatological science,
Janna Paulsson, and Tobias Sjöblom, and Patrick Micke, and Fredrik Pontén, and Göran Landberg, and Carl-Henrik Heldin, and Jonas Bergh, and Donal J Brennan, and Karin Jirström, and Arne Ostman
January 2004, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!